Medicamen Organics Limited has submitted a Compliance Certificate for the Structured Digital Database (SDD) for the financial year ending March 31, 2025. The company confirms its compliance with SDD requirements as per SEBI's Prohibition of Insider Trading Regulations. A Practicing Company Secretary has certified that the company maintains a non-tamperable database with appropriate access controls and that it has captured all necessary Unpublished Price Sensitive Information (UPSI) events during the financial year. The internal system is designed to retain records for eight years. This compliance is crucial for maintaining investor confidence and transparency, enhancing the company's reputation in the market. Shareholders should view this development positively as it reflects the company's commitment to regulatory adherence and governance standards.